Process development and scale-up work is carried out to establish a process, which can be transferred to the manufacturing facility. Many of our customers are virtual or small companies. These companies are skilled in cloning and screening for new therapeutic proteins and monoclonal antibodies, but often lack scale-up expertise. Our Process Development group can be a valuable partner in your success. We understand bioreactor cell culture and the bioprocesses required to produce a wide variety of monoclonal antibodies, recombinant proteins and enzymes.